| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:10730 | 6480464 | epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA]; more ... | CTD | PMID:18656336 |
| (S)-nicotine | increases activity | ISO | RGD:2827 | 6480464 | Nicotine results in increased activity of HRAS protein | CTD | PMID:15983034 |
| (S)-nicotine | multiple interactions | ISO | RGD:10730 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS1 mRNA; more ... | CTD | PMID:20230807 |
| 1,2-dichlorobenzene | increases expression | ISO | RGD:2827 | 6480464 | 2-dichlorobenzene results in increased expression of HRAS mRNA | CTD | PMID:10614693 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:10730 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HRAS1 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:10730 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS1 mRNA; more ... | CTD | PMID:20230807 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2827 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of HRAS mRNA | CTD | PMID:20551477 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10730 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10730 | 6480464 | Ethinyl Estradiol results in increased expression of HRAS1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of HRAS mRNA | CTD | PMID:21826169 |
| 17beta-estradiol | increases expression | ISO | RGD:10730 | 6480464 | Estradiol results in increased expression of HRAS1 mRNA | CTD | PMID:22467019 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of HRAS mRNA | CTD | PMID:16051634 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | CTD | PMID:12117780 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] | CTD | PMID:16051634 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10730 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HRAS1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10730 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HRAS1 mRNA | CTD | PMID:21354282 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2827 | 6480464 | 2,4-dinitrotoluene affects the expression of HRAS mRNA | CTD | PMID:21346803 |
| 2,6-di-tert-butyl-4-methylphenol | decreases methylation | ISO | RGD:2827 | 6480464 | Butylated Hydroxytoluene results in decreased methylation of HRAS gene | CTD | PMID:9780227 |
| 2,6-di-tert-butyl-4-methylphenol | increases response to substance | ISO | RGD:10730 | 6480464 | HRAS1 protein results in increased susceptibility to Butylated Hydroxytoluene | CTD | PMID:11599794 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2827 | 6480464 | 2,6-dinitrotoluene affects the expression of HRAS mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:2827 | 6480464 | 2-Acetylaminofluorene results in increased expression of HRAS protein | CTD | PMID:11350689 |
| 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | EXP | | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]] | CTD | PMID:18625914 |
| 2-trans,6-trans-farnesyl diphosphate | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]]; more ... | CTD | PMID:18625914 |
| 4-hydroperoxycyclophosphamide | decreases expression | ISO | RGD:10730 | 6480464 | perfosfamide results in decreased expression of HRAS1 mRNA | CTD | PMID:19429390 |
| 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:10730 | 6480464 | Fenretinide results in decreased expression of HRAS1 mRNA | CTD | PMID:16467112 |
| 4-nitrophenol | affects glucuronidation | EXP | | 6480464 | HRAS protein affects the glucuronidation of 4-nitrophenol | CTD | PMID:11695553 |
| 4-nitroquinoline N-oxide | multiple interactions | EXP | | 6480464 | [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA; more ... | CTD | PMID:20043093 |
| 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | decitabine results in decreased expression of HRAS mRNA | CTD | PMID:19027819 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of HRAS mRNA | CTD | PMID:16557594 |
| 7,12-dimethyltetraphene | increases mutagenesis | ISO | RGD:10730 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene | CTD | PMID:20103723 |
| 7,12-dimethyltetraphene | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:11376698 PMID:12117780 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:11241758 PMID:3115617 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:3115617 PMID:11241758 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS1 mRNA; more ... | CTD | PMID:3115617 |
| 7,12-dimethyltetraphene | increases mutagenesis | ISO | RGD:10730 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene | CTD | PMID:1375869 |
| 7,12-dimethyltetraphene | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:12117780 PMID:11376698 |
| 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; more ... | CTD | PMID:12117780 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10730 | 6480464 | [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:20103723 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin promotes the reaction [[Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene] | CTD | PMID:9345283 |
| ADP | multiple interactions | EXP | | 6480464 | Adenosine Diphosphate binds to and affects the folding of HRAS protein | CTD | PMID:16388579 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of HRAS protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of HRAS mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | increases expression | ISO | RGD:10730 | 6480464 | Aflatoxin B1 results in increased expression of HRAS1 mRNA | CTD | PMID:19770486 |
| alendronic acid | decreases prenylation | ISO | RGD:10730 | 6480464 | Alendronate results in decreased prenylation of HRAS protein | CTD | PMID:9556058 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:10730 | 6480464 | Tretinoin results in decreased expression of HRAS1 mRNA | CTD | PMID:16604517 |
| aluminium trichloride | increases expression | ISO | RGD:2827 | 6480464 | aluminum chloride results in increased expression of HRAS mRNA | CTD | PMID:22079183 |
| aristolochic acid | increases mutagenesis | ISO | RGD:2827 | 6480464 | aristolochic acid I results in increased mutagenesis of HRAS gene | CTD | PMID:21642617 |
| Aroclor 1254 | increases expression | ISO | RGD:2827 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of HRAS mRNA | CTD | PMID:8471063 |
| aspartame | increases expression | ISO | RGD:10730 | 6480464 | Aspartame results in increased expression of HRAS1 | CTD | PMID:17354619 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene metabolite results in increased expression of HRAS mRNA; more ... | CTD | PMID:11008122 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of HRAS mRNA | CTD | PMID:11008122 PMID:21632981 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10730 | 6480464 | Benzo(a)pyrene results in decreased expression of HRAS1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | increases response to substance | EXP | | 6480464 | HRAS mRNA results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:22048643 |
| benzo[a]pyrene | increases expression | ISO | RGD:10730 | 6480464 | Benzo(a)pyrene results in increased expression of HRAS1 mRNA | CTD | PMID:20504355 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10730 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of HRAS1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10730 | 6480464 | [Benzo(a)pyrene co-treated with Tetradecanoylphorbol Acetate] affects the mutagenesis of HRAS1 gene | CTD | PMID:11765016 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:2827 | 6480464 | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA]; more ... | CTD | PMID:20064080 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:2827 | 6480464 | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA; more ... | CTD | PMID:19408242 |
| benzo[a]pyrene | increases expression | ISO | RGD:2827 | 6480464 | Benzo(a)pyrene results in increased expression of HRAS protein; more ... | CTD | PMID:19408242 PMID:20064080 |
| benzo[a]pyrene | increases expression | ISO | RGD:2827 | 6480464 | Benzo(a)pyrene results in increased expression of HRAS mRNA; more ... | CTD | PMID:20064080 PMID:19408242 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10730 | 6480464 | epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA]; more ... | CTD | PMID:18656336 |
| benzo[a]pyrene | increases expression | ISO | RGD:10730 | 6480464 | Benzo(a)pyrene results in increased expression of HRAS mRNA; more ... | CTD | PMID:18656336 |
| beryllium atom | increases mutagenesis | ISO | RGD:2827 | 6480464 | Beryllium results in increased mutagenesis of HRAS gene | CTD | PMID:7545909 |
| beryllium(0) | increases mutagenesis | ISO | RGD:2827 | 6480464 | Beryllium results in increased mutagenesis of HRAS gene | CTD | PMID:7545909 |
| biphenyl-2-ol | multiple interactions | EXP | | 6480464 | bathocuproine inhibits the reaction [[2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:10334203 |
| biphenyl-4-amine | increases mutagenesis | ISO | RGD:10730 | 6480464 | 4-biphenylamine results in increased mutagenesis of HRAS1 gene | CTD | PMID:15761837 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of HRAS mRNA | CTD | PMID:21826169 |
| buta-1,3-diene | increases mutagenesis | ISO | RGD:10730 | 6480464 | 1,3-butadiene results in increased mutagenesis of HRAS1 gene | CTD | PMID:11397402 |
| caffeine | multiple interactions | ISO | RGD:10730 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HRAS1 mRNA; more ... | CTD | PMID:20230807 |
| capecitabine | decreases response to substance | EXP | | 6480464 | HRAS protein results in decreased susceptibility to capecitabine | CTD | PMID:16734730 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of HRAS mRNA | CTD | PMID:9461043 |
| chloroprene | increases mutagenesis | ISO | RGD:10730 | 6480464 | Chloroprene results in increased mutagenesis of HRAS1 gene | CTD | PMID:11397402 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:10730 | 6480464 | Ciguatoxins affects the expression of HRAS1 mRNA | CTD | PMID:18353800 |
| cisplatin | decreases response to substance | EXP | | 6480464 | HRAS results in decreased susceptibility to Cisplatin | CTD | PMID:21849418 |
| cisplatin | increases expression | ISO | RGD:2827 | 6480464 | Cisplatin results in increased expression of HRAS mRNA | CTD | PMID:18172885 |
| copper atom | multiple interactions | EXP | | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:10334203 |
| copper atom | multiple interactions | EXP | | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | CTD | PMID:11275476 |
| copper(0) | multiple interactions | EXP | | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:10334203 |
| copper(0) | multiple interactions | EXP | | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | CTD | PMID:11275476 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of HRAS mRNA | CTD | PMID:19549813 |
| D-glucose | increases activity | ISO | RGD:2827 | 6480464 | Glucose results in increased activity of HRAS protein | CTD | PMID:16572112 |
| D-glucose | multiple interactions | ISO | RGD:2827 | 6480464 | manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | CTD | PMID:16572112 |
| deoxycholic acid | increases activity | EXP | | 6480464 | Deoxycholic Acid results in increased activity of HRAS protein | CTD | PMID:18444174 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] | CTD | PMID:10807665 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | CTD | PMID:18922899 |
| diazoxide | increases activity | ISO | RGD:2827 | 6480464 | Isoproterenol results in increased activity of HRAS protein | CTD | PMID:8484791 |
| dichlorine | multiple interactions | ISO | RGD:2827 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | CTD | PMID:18636392 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | docetaxel results in increased expression of and results in increased activity of HRAS protein | CTD | PMID:15970518 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of HRAS mRNA | CTD | PMID:16001973 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | CTD | PMID:19244175 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of HRAS mRNA | CTD | PMID:19244175 |
| ellagic acid | multiple interactions | ISO | RGD:10730 | 6480464 | [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:20103723 |
| eugenol | decreases expression | ISO | RGD:10730 | 6480464 | Eugenol results in decreased expression of HRAS1 protein | CTD | PMID:20537511 |
| farnesyl diphosphate | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased activity of HRAS protein]]; more ... | CTD | PMID:18625914 |
| fenofibrate | multiple interactions | ISO | RGD:10730 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of HRAS1 mRNA | CTD | PMID:18978307 |
| flurbiprofen | multiple interactions | ISO | RGD:10730 | 6480464 | HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | CTD | PMID:16949054 |
| gliotoxin | multiple interactions | ISO | RGD:10730 | 6480464 | Gliotoxin inhibits the reaction [Acetaminophen results in increased activity of HRAS1 protein] | CTD | PMID:19739265 |
| glucaric acid | multiple interactions | ISO | RGD:10730 | 6480464 | [Glucaric Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:20103723 |
| glucose | increases activity | ISO | RGD:2827 | 6480464 | Glucose results in increased activity of HRAS protein | CTD | PMID:16572112 |
| glucose | multiple interactions | ISO | RGD:2827 | 6480464 | manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | CTD | PMID:16572112 |
| glutathione | multiple interactions | EXP | | 6480464 | [Zinostatin co-treated with Glutathione] results in increased cleavage of HRAS gene; more ... | CTD | PMID:9345283 |
| glycyrrhetinate | decreases expression | EXP | | 6480464 | Glycyrrhetinic Acid results in decreased expression of HRAS protein | CTD | PMID:19958823 |
| glycyrrhetinic acid | decreases expression | EXP | | 6480464 | Glycyrrhetinic Acid results in decreased expression of HRAS protein | CTD | PMID:19958823 |
| Goe 6976 | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein] | CTD | PMID:19133285 |
| heptachlor | decreases expression | EXP | | 6480464 | Heptachlor results in decreased expression of HRAS mRNA | CTD | PMID:1771636 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of HRAS mRNA | CTD | PMID:11008122 |
| hydrogen peroxide | multiple interactions | ISO | RGD:10730 | 6480464 | HRAS protein affects the susceptibility to [Hydrogen Peroxide results in increased activity of MAPK1 protein]; more ... | CTD | PMID:14975446 |
| iron atom | multiple interactions | ISO | RGD:2827 | 6480464 | HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein]; more ... | CTD | PMID:17172471 |
| iron atom | affects localization | ISO | RGD:2827 | 6480464 | Iron affects the localization of HRAS protein | CTD | PMID:17172471 |
| isoprenaline | increases activity | ISO | RGD:2827 | 6480464 | Isoproterenol results in increased activity of HRAS protein | CTD | PMID:8484791 |
| isoprene | increases mutagenesis | ISO | RGD:10730 | 6480464 | isoprene results in increased mutagenesis of HRAS1 gene | CTD | PMID:9111215 PMID:11397402 |
| isoprene | increases mutagenesis | ISO | RGD:10730 | 6480464 | isoprene results in increased mutagenesis of HRAS1 gene | CTD | PMID:11397402 PMID:9111215 |
| ketamine | multiple interactions | ISO | RGD:10730 | 6480464 | Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS1 protein] | CTD | PMID:19540866 |
| lead diacetate | multiple interactions | ISO | RGD:2827 | 6480464 | lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | CTD | PMID:15111246 |
| lead diacetate | increases activity | EXP | | 6480464 | lead acetate results in increased activity of HRAS protein | CTD | PMID:19133285 |
| lead diacetate | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein]; more ... | CTD | PMID:19133285 |
| lead(0) | multiple interactions | ISO | RGD:2827 | 6480464 | Lead inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | CTD | PMID:15111246 |
| limonene | multiple interactions | EXP | | 6480464 | limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | CTD | PMID:11802805 |
| lovastatin | decreases prenylation | EXP | | 6480464 | Lovastatin results in decreased prenylation of HRAS protein | CTD | PMID:16156861 |
| lovastatin | multiple interactions | EXP | | 6480464 | Lovastatin results in decreased prenylation of and results in decreased localization of HRAS protein | CTD | PMID:19360310 |
| malathion | multiple interactions | EXP | | 6480464 | [Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA | CTD | PMID:18204794 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of HRAS1 protein | CTD | PMID:19787260 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of HRAS mRNA | CTD | PMID:18204794 |
| mercury atom | multiple interactions | ISO | RGD:2827 | 6480464 | Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] | CTD | PMID:15111246 |
| mercury dichloride | multiple interactions | ISO | RGD:2827 | 6480464 | Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer] | CTD | PMID:15111246 |
| mercury(0) | multiple interactions | ISO | RGD:2827 | 6480464 | Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] | CTD | PMID:15111246 |
| methamphetamine | decreases expression | ISO | RGD:2827 | 6480464 | Methamphetamine results in decreased expression of HRAS mRNA | CTD | PMID:15644446 |
| methylglyoxal | increases activity | ISO | RGD:2827 | 6480464 | Pyruvaldehyde results in increased activity of HRAS1 protein | CTD | PMID:17635749 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to HRAS protein]]] | CTD | PMID:10807665 |
| myricetin | decreases activity | ISO | RGD:10730 | 6480464 | myricetin results in decreased activity of HRAS1 protein | CTD | PMID:17693661 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2827 | 6480464 | Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] | CTD | PMID:15945272 |
| N-ethyl-N-nitrosourea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Ethylnitrosourea | CTD | PMID:11182032 |
| N-hydroxy-4-aminobiphenyl | multiple interactions | EXP | | 6480464 | [N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | CTD | PMID:11275476 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | Methylnitronitrosoguanidine inhibits the reaction [EGF protein results in increased activity of HRAS protein] | CTD | PMID:15708576 |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:12117780 more ... |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11182032 more ... |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11376698 more ... |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11182032 more ... |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11376698 more ... |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11802805 more ... |
| N-methyl-N-nitrosurea | increases mutagenesis | ISO | RGD:2827 | 6480464 | Methylnitrosourea results in increased mutagenesis of HRAS gene | CTD | PMID:10767621 PMID:15688392 |
| N-methyl-N-nitrosurea | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Methylnitrosourea | CTD | PMID:11376698 more ... |
| N-methyl-N-nitrosurea | increases mutagenesis | ISO | RGD:2827 | 6480464 | Methylnitrosourea results in increased mutagenesis of HRAS gene | CTD | PMID:15688392 PMID:10767621 |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:2827 | 6480464 | HRAS protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:11973638 |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | CTD | PMID:11802805 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10730 | 6480464 | [Diethylnitrosamine co-treated with HRAS protein] results in increased activity of MDH1 protein; more ... | CTD | PMID:12499697 |
| N-nitrosodiethylamine | increases mutagenesis | ISO | RGD:10730 | 6480464 | Diethylnitrosamine results in increased mutagenesis of HRAS1 gene | CTD | PMID:2675901 PMID:15592514 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10730 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of HRAS1 mRNA | CTD | PMID:18978307 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2827 | 6480464 | Diethylnitrosamine results in increased expression of HRAS mRNA | CTD | PMID:7910516 |
| N-nitrosodiethylamine | increases mutagenesis | ISO | RGD:10730 | 6480464 | Diethylnitrosamine results in increased mutagenesis of HRAS1 gene | CTD | PMID:15592514 PMID:2675901 |
| NAD zwitterion | multiple interactions | EXP | | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:10334203 |
| NAD(+) | multiple interactions | EXP | | 6480464 | [2-phenylphenol metabolite co-treated with NAD co-treated with Copper] results in increased mutagenesis of HRAS1 gene; more ... | CTD | PMID:10334203 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of CCND1 mRNA]; more ... | CTD | PMID:20043093 |
| ochratoxin A | increases expression | ISO | RGD:2827 | 6480464 | ochratoxin A results in increased expression of HRAS mRNA | CTD | PMID:23358140 |
| ozone | multiple interactions | ISO | RGD:2827 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | ISO | RGD:10730 | 6480464 | Acetaminophen affects the expression of HRAS1 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:10730 | 6480464 | manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS1 protein]; more ... | CTD | PMID:19739265 |
| paracetamol | increases activity | ISO | RGD:10730 | 6480464 | Acetaminophen results in increased activity of HRAS1 protein | CTD | PMID:19739265 |
| parathion | multiple interactions | EXP | | 6480464 | [Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA | CTD | PMID:18204794 |
| parathion | increases expression | EXP | | 6480464 | Parathion results in increased expression of HRAS1 protein | CTD | PMID:19787260 |
| phenobarbital | decreases mutagenesis | ISO | RGD:10730 | 6480464 | Phenobarbital results in decreased mutagenesis of HRAS protein | CTD | PMID:11753661 |
| phlorizin | increases expression | ISO | RGD:10730 | 6480464 | Phlorhizin results in increased expression of HRAS mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | CTD | PMID:18922899 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS1 gene | CTD | PMID:11241758 PMID:3115617 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | [Benzo(a)pyrene co-treated with Tetradecanoylphorbol Acetate] affects the mutagenesis of HRAS1 gene | CTD | PMID:11765016 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS1 mRNA; more ... | CTD | PMID:3115617 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS1 gene | CTD | PMID:3115617 PMID:11241758 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene | CTD | PMID:9766437 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10730 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA | CTD | PMID:17106253 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10730 | 6480464 | bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA] | CTD | PMID:17106253 |
| plutonium atom | increases mutagenesis | ISO | RGD:2827 | 6480464 | Plutonium results in increased mutagenesis of HRAS gene | CTD | PMID:9255578 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of HRAS mRNA; more ... | CTD | PMID:10652438 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of HRAS mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:10730 | 6480464 | [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:20103723 |
| resveratrol | multiple interactions | EXP | | 6480464 | HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein]; more ... | CTD | PMID:11889192 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of HRAS mRNA mutant form; more ... | CTD | PMID:16369916 |
| rotenone | decreases expression | ISO | RGD:10730 | 6480464 | Rotenone results in decreased expression of HRAS mRNA | CTD | PMID:10630619 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | CTD | PMID:19244175 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of HRAS mRNA | CTD | PMID:19244175 |
| simvastatin | multiple interactions | EXP | | 6480464 | farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased localization of HRAS protein]]; more ... | CTD | PMID:18625914 |
| simvastatin | decreases activity | ISO | RGD:10730 | 6480464 | Simvastatin results in decreased activity of HRAS1 | CTD | PMID:11914545 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin results in decreased prenylation of and results in decreased localization of HRAS protein | CTD | PMID:19360310 |
| sulfur dioxide | multiple interactions | ISO | RGD:2827 | 6480464 | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA; more ... | CTD | PMID:19408242 |
| sulfur dioxide | increases expression | ISO | RGD:2827 | 6480464 | Sulfur Dioxide results in increased expression of HRAS protein; more ... | CTD | PMID:19408242 PMID:20064080 |
| sulfur dioxide | increases expression | ISO | RGD:2827 | 6480464 | Sulfur Dioxide results in increased expression of HRAS mRNA; more ... | CTD | PMID:20064080 PMID:19408242 |
| sulfur dioxide | multiple interactions | ISO | RGD:2827 | 6480464 | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS protein]; more ... | CTD | PMID:20064080 |
| superoxide | increases abundance | EXP | | 6480464 | HRAS protein mutant form results in increased abundance of Superoxides | CTD | PMID:11313892 |
| superoxide | multiple interactions | EXP | | 6480464 | [HRAS protein mutant form results in increased abundance of Superoxides] which results in decreased susceptibility to TNF protein | CTD | PMID:11313892 |
| testosterone | decreases expression | ISO | RGD:10730 | 6480464 | Testosterone results in decreased expression of HRAS1 mRNA | CTD | PMID:20403060 |
| tetrachloromethane | increases expression | ISO | RGD:2827 | 6480464 | Carbon Tetrachloride results in increased expression of HRAS mRNA | CTD | PMID:8847708 |
| toluene | affects expression | ISO | RGD:2827 | 6480464 | Toluene affects the expression of HRAS mRNA | CTD | PMID:21827849 |
| trans-resveratrol | multiple interactions | ISO | RGD:10730 | 6480464 | [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS1 gene]; more ... | CTD | PMID:20103723 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | HRAS protein promotes the reaction [resveratrol results in increased activity of MAPK1 protein]; more ... | CTD | PMID:11889192 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of HRAS mRNA mutant form; more ... | CTD | PMID:16369916 |
| trimethyltin | increases expression | ISO | RGD:10730 | 6480464 | trimethyltin results in increased expression of HRAS1 mRNA | CTD | PMID:21435392 |
| troglitazone | increases expression | ISO | RGD:10730 | 6480464 | troglitazone results in increased expression of HRAS1 mRNA | CTD | PMID:17569031 |
| urethane | multiple interactions | EXP | | 6480464 | HRAS protein promotes the reaction [Urethane results in increased expression of CCND1 protein] | CTD | PMID:11307925 |
| urethane | increases expression | ISO | RGD:10730 | 6480464 | Urethane results in increased expression of HRAS1 mRNA | CTD | PMID:18465119 |
| urethane | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Urethane | CTD | PMID:11552296 PMID:10779650 |
| urethane | increases mutagenesis | EXP | | 6480464 | Urethane results in increased mutagenesis of HRAS gene | CTD | PMID:10779650 PMID:12765245 |
| urethane | multiple interactions | ISO | RGD:10730 | 6480464 | tocopheryloxybutyric acid inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS1 protein]]; more ... | CTD | PMID:11062179 |
| urethane | increases response to substance | ISO | RGD:10730 | 6480464 | HRAS1 protein results in increased susceptibility to Urethane | CTD | PMID:15902970 |
| urethane | increases response to substance | EXP | | 6480464 | HRAS protein results in increased susceptibility to Urethane | CTD | PMID:10779650 PMID:11552296 |
| urethane | increases mutagenesis | EXP | | 6480464 | Urethane results in increased mutagenesis of HRAS gene | CTD | PMID:12765245 PMID:10779650 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:2827 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of HRAS protein] | CTD | PMID:12839936 |
| vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of HRAS mRNA | CTD | PMID:16001973 |
| vinyl carbamate | increases mutagenesis | EXP | | 6480464 | vinyl carbamate results in increased mutagenesis of HRAS gene | CTD | PMID:12765245 |
| zidovudine | multiple interactions | ISO | RGD:10730 | 6480464 | [Zidovudine co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene | CTD | PMID:9766437 |
| zoledronic acid | decreases localization | EXP | | 6480464 | zoledronic acid results in decreased localization of HRAS protein | CTD | PMID:11986784 |